STOCK TITAN
  1. Home
  2. News
  3. GEHC

GE HealthCare Technologies Inc. - GEHC STOCK NEWS

Welcome to our dedicated page for GE HealthCare Technologies news (Ticker: GEHC), a resource for investors and traders seeking the latest updates and insights on GE HealthCare Technologies stock.

GE HealthCare Technologies Inc. (NYSE: GEHC) is a leading global innovator in medical technology, pharmaceutical diagnostics, and digital solutions. The company operates through four main segments: Imaging, Ultrasound, Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). Of these, the Imaging segment generates the majority of the company’s revenue.

GE HealthCare is dedicated to providing transformational medical technologies and services that enhance access to quality, affordable healthcare worldwide. Through its cutting-edge products and comprehensive solutions, the company aims to improve patient outcomes and streamline healthcare delivery.

Recent achievements include advancements in artificial intelligence (AI) integration within medical imaging, which supports more accurate and efficient diagnostics. The company is also involved in numerous partnerships with healthcare providers and research institutions to drive innovation and improve global healthcare standards.

Financially, GE HealthCare has showcased robust performance, with steady revenue growth and strong market presence. The company continuously invests in R&D to maintain its edge in the competitive healthcare industry. Their suite of products includes advanced imaging machines, ultrasound devices, patient monitoring systems, and contrast media for diagnostic imaging.

As part of a highly regulated industry, GE HealthCare adheres to strict compliance standards and maintains rigorous quality controls across its operations. The company actively engages with its community, although it reserves the right to monitor and manage public interactions to uphold professional and constructive discourse.

News

Expanding the Reach of Care for Cancer and Other Disease States: BAMF Health and GE HealthCare collaborate to enable sustainable and scalable solutions for growth in Theranostics

Rhea-AI Summary
GE HealthCare (GE) and BAMF Health announce a collaboration to expand patient and clinician access to Theranostic care, aiming to transform cancer and disease treatment. The partnership will scale turnkey offerings inclusive of leading GE HealthCare technologies, with a focus on enhancing the adoption of Theranostics solutions in the U.S. Theranostics combines imaging technology and targeted therapies to identify and treat diseases, showing crucial improvements in personalized care for patients battling complex cancers. The collaboration will leverage both partners' expertise to establish a framework for expanded adoption of precision care, with GE HealthCare's comprehensive solutions and BAMF Health's expertise in scaling molecular imaging and Theranostics.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.7%
Tags
none
-
News

GE HealthCare and Masimo Collaborate to Bring Masimo SET® Pulse Oximetry to the Wireless and Wearable GE HealthCare Portrait Mobile Platform

Rhea-AI Summary
GE HealthCare (GEHC) and Masimo (MASI) have announced a joint agreement to integrate Masimo Signal Extraction Technology® (SET®) pulse oximetry into GE HealthCare’s Portrait Mobile wireless and wearable patient monitoring solution. The integration will allow clinicians to leverage Masimo’s clinically proven oxygen saturation measurement technology to noninvasively detect and continuously monitor changes in patient status. This collaboration follows Portrait Mobile’s 510(k) clearance from the U.S. FDA in August 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1%
Tags
none
-
News

GE HealthCare Announces New Data Validating Artificial Intelligence Models for Predicting Patient Response to Immunotherapies

Rhea-AI Summary
GE HealthCare's AI models predict patient response to immunotherapies with 70-80% accuracy, potentially enabling personalized treatment and reducing side effects and costs.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.42%
Tags
none
News

GE HealthCare Reports Third Quarter 2023 Financial Results

Rhea-AI Summary
GE HealthCare reported a 5% year-over-year revenue growth and a net income of $375 million. The company raised the low end of its full-year Adjusted EPS guidance range. The third quarter total company financial performance showed a 5% increase in revenues, with a book-to-bill ratio of 1.03 times. The Imaging segment had a 5% revenue growth, while the Ultrasound segment declined by 1%. The Patient Care Solutions segment had a 9% revenue growth, and the Pharmaceutical Diagnostics segment had a 13% revenue growth.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.38%
Tags
earnings
-
News

GE HealthCare and reLink Medical Collaborate to Help Reduce Medical Device Waste for Healthcare Providers

Rhea-AI Summary
GE HealthCare and reLink Medical collaborate to deliver asset management solutions to healthcare providers, helping reduce medical device waste and increase operational efficiency. The collaboration offers a standardized medical equipment disposition solution involving selling, recycling, or donating equipment that is no longer needed. The collaboration aims to support healthcare providers in disposing of medical equipment in a safe, compliant, and environmentally responsible manner.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.93%
Tags
none
-
News

GE HealthCare Tops List with Highest Number of AI-Enabled Medical Device Authorizations, Developing Innovative Solutions for Precision Care

Rhea-AI Summary
GE HealthCare tops FDA list of AI-enabled medical devices with 58 authorizations, showcasing the company's focus on precision care and digital solutions. The devices include deep learning technology for faster MRI scans, AI-driven cardiac ultrasound guidance, and more.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.06%
Tags
AI
News

GE HealthCare Announces New Innovations and Collaborations in Image Guided Therapy as part of TCT2023 Cardiology Care Pathway Showcase

Rhea-AI Summary
GE HealthCare will showcase new technologies in interventional cardiology at the 2023 Transcatheter Cardiovascular Therapeutics conference. The innovations include the Allia IGS Pulse image-guided system, INTERACT Touch for multi-modality integration, and the 3D Stent for augmented imaging. The company aims to optimize workflows, increase collaboration, and drive better patient outcomes in the treatment of cardiovascular disease.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.09%
Tags
none
-
News

GE HealthCare and Novo Nordisk to Collaborate to Advance Novel Non-Invasive Treatment for Type 2 Diabetes and Obesity with Ultrasound

Rhea-AI Summary
GE HealthCare collaborates with Novo Nordisk to develop peripheral focused ultrasound therapy for chronic disease management
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.34%
Tags
none
-
News

GE HealthCare to Announce Third Quarter 2023 Results on October 31, 2023

Rhea-AI Summary
GE HealthCare to announce Q3 2023 financial results
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.12%
Tags
earnings
News

GE HealthCare Receives FDA Clearance of Allia IGS Pulse - the Next Generation of Image-Guided Systems Designed for Cardiac Imaging Excellence

Rhea-AI Summary
GE HealthCare announces FDA clearance of Allia IGS Pulse, a new image guided system for cardiovascular diseases in interventional cardiology.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.36%
Tags
clinical trial

FAQ

What is the current stock price of GE HealthCare Technologies (GEHC)?

The current stock price of GE HealthCare Technologies (GEHC) is $82.44 as of November 22, 2024.

What is the market cap of GE HealthCare Technologies (GEHC)?

The market cap of GE HealthCare Technologies (GEHC) is approximately 36.9B.

What does GE HealthCare Technologies Inc. do?

GE HealthCare Technologies Inc. provides transformative medical technologies, pharmaceutical diagnostics, and digital solutions to improve healthcare access and quality globally.

What are the main business segments of GE HealthCare?

The main business segments are Imaging, Ultrasound, Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx).

How does GE HealthCare generate most of its revenue?

The company generates the majority of its revenue from the Imaging segment.

What recent advancements has GE HealthCare made?

GE HealthCare has made significant advancements in AI integration within medical imaging, improving diagnostic accuracy and efficiency.

Who are GE HealthCare's partners?

The company collaborates with healthcare providers and research institutions to drive innovation and improve healthcare standards.

How does GE HealthCare ensure compliance?

GE HealthCare adheres to strict regulatory compliance standards and maintains rigorous quality controls across its operations.

What products does GE HealthCare offer?

GE HealthCare offers a range of products, including imaging machines, ultrasound devices, patient monitoring systems, and diagnostic contrast media.

What is GE HealthCare's commitment to the community?

The company engages actively with its community and strives to maintain professional and positive interactions while monitoring public posts and conversations.

How has GE HealthCare performed financially?

GE HealthCare has shown robust financial performance with steady revenue growth, supported by continuous investment in research and development.

What is GE HealthCare's mission?

GE HealthCare is committed to improving patient outcomes and making quality healthcare more accessible and affordable worldwide.

Stock GEHC logo
GE HealthCare Technologies Inc.

Nasdaq:GEHC

GEHC Rankings

#354 Ranked by Market Cap
#2112 Ranked by Dividends

GEHC Stock Data

36.94B
442.78M
3.09%
83.51%
1.81%
Health Information Services
X-ray Apparatus & Tubes & Related Irradiation Apparatus
Link
United States of America
CHICAGO